| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.979 | 0.004 | 0.985 | Analgesic | 0.98 0.004 DB00956 0.98 0.004 DBMET00420 0.985 0.003 DB00327 0.965 0.004 DBMET02686 0.965 0.004 DBMET02687 0.979 0.004 DBMET02685 0.979 0.004 DBMET02684 0.921 0.004 DBMET02726 0.93 0.004 DBMET02727 0.921 0.004 DBMET02724 0.93 0.004 DBMET02725 | DB00327 | |
| 0.927 | 0.002 | 0.969 | Analgesic, opioid | 0.948 0.002 DB00956 0.926 0.002 DBMET00420 0.969 0.001 DB00327 0.902 0.002 DBMET02686 0.902 0.002 DBMET02687 0.941 0.002 DBMET02685 0.941 0.002 DBMET02684 0.787 0.002 DBMET02726 0.823 0.002 DBMET02727 0.787 0.002 DBMET02724 0.823 0.002 DBMET02725 | DB00327 | |
| 0.883 | 0.003 | 0.958 | Psychostimulant | 0.957 0.002 DB00956 0.903 0.003 DBMET00420 0.958 0.002 DB00327 0.917 0.003 DBMET02686 0.917 0.003 DBMET02687 0.917 0.003 DBMET02685 0.917 0.003 DBMET02684 0.939 0.002 DBMET02726 0.925 0.002 DBMET02727 0.939 0.002 DBMET02724 0.925 0.002 DBMET02725 | DB00327 | |
| 0.862 | 0.002 | 0.926 | Opioid agonist | 0.894 0.001 DB00956 0.859 0.002 DBMET00420 0.926 0.001 DB00327 0.809 0.002 DBMET02686 0.809 0.002 DBMET02687 0.867 0.002 DBMET02685 0.867 0.002 DBMET02684 0.719 0.003 DBMET02726 0.749 0.002 DBMET02727 0.719 0.003 DBMET02724 0.749 0.002 DBMET02725 | DB00327 | |
| 0.835 | 0.002 | 0.905 | Opioid antagonist | 0.87 0.001 DB00956 0.853 0.002 DBMET00420 0.905 0.001 DB00327 0.834 0.002 DBMET02686 0.834 0.002 DBMET02687 0.86 0.002 DBMET02685 0.86 0.002 DBMET02684 0.767 0.003 DBMET02726 0.792 0.002 DBMET02727 0.767 0.003 DBMET02724 0.792 0.002 DBMET02725 | DB00327 | |
| 0.827 | 0.001 | 0.906 | Opioid mu receptor agonist | 0.876 0.001 DB00956 0.824 0.001 DBMET00420 0.906 0.001 DB00327 0.767 0.002 DBMET02686 0.767 0.002 DBMET02687 0.835 0.001 DBMET02685 0.835 0.001 DBMET02684 0.67 0.002 DBMET02726 0.688 0.002 DBMET02727 0.67 0.002 DBMET02724 0.688 0.002 DBMET02725 | DB00327 | |
| 0.809 | 0.002 | 0.902 | Opioid mu receptor antagonist | 0.856 0.001 DB00956 0.833 0.001 DBMET00420 0.902 0.001 DB00327 0.808 0.002 DBMET02686 0.808 0.002 DBMET02687 0.844 0.001 DBMET02685 0.844 0.001 DBMET02684 0.728 0.002 DBMET02726 0.765 0.002 DBMET02727 0.728 0.002 DBMET02724 0.765 0.002 DBMET02725 | DB00327 | |
| 0.758 | 0.002 | 0.848 | Opioid delta receptor antagonist | 0.803 0.001 DB00956 0.786 0.002 DBMET00420 0.848 0.001 DB00327 0.763 0.002 DBMET02686 0.763 0.002 DBMET02687 0.789 0.002 DBMET02685 0.789 0.002 DBMET02684 0.677 0.003 DBMET02726 0.714 0.002 DBMET02727 0.677 0.003 DBMET02724 0.714 0.002 DBMET02725 | DB00327 | |
| 0.736 | 0.002 | 0.818 | Opioid kappa receptor antagonist | 0.784 0.001 DB00956 0.765 0.001 DBMET00420 0.818 0.001 DB00327 0.746 0.002 DBMET02686 0.746 0.002 DBMET02687 0.773 0.001 DBMET02685 0.773 0.001 DBMET02684 0.644 0.002 DBMET02726 0.674 0.002 DBMET02727 0.644 0.002 DBMET02724 0.674 0.002 DBMET02725 | DB00327 | |
| 0.676 | 0.002 | 0.85 | Opioid delta receptor agonist | 0.804 0.002 DB00956 0.764 0.002 DBMET00420 0.85 0.001 DB00327 0.668 0.002 DBMET02686 0.668 0.002 DBMET02687 0.738 0.002 DBMET02685 0.738 0.002 DBMET02684 0.526 0.003 DBMET02726 0.576 0.003 DBMET02727 0.526 0.003 DBMET02724 0.576 0.003 DBMET02725 | DB00327 | |
| 0.658 | 0.008 | 0.872 | Spasmolytic | 0.59 0.014 DB00956 0.446 0.032 DBMET00420 0.629 0.01 DB00327 0.84 0.004 DBMET02686 0.84 0.004 DBMET02687 0.855 0.004 DBMET02685 0.855 0.004 DBMET02684 0.872 0.004 DBMET02726 0.842 0.004 DBMET02727 0.872 0.004 DBMET02724 0.842 0.004 DBMET02725 | DBMET02724 | |
| 0.629 | 0.004 | 0.656 | Sigma receptor agonist | 0.653 0.003 DB00956 0.528 0.007 DBMET00420 0.646 0.004 DB00327 0.652 0.003 DBMET02686 0.652 0.003 DBMET02687 0.656 0.003 DBMET02685 0.656 0.003 DBMET02684 0.551 0.006 DBMET02726 0.547 0.006 DBMET02727 0.551 0.006 DBMET02724 0.547 0.006 DBMET02725 | DBMET02684 | |
| 0.55 | 0.005 | 0.797 | Anesthetic general | 0.703 0.003 DB00956 0.559 0.005 DBMET00420 0.754 0.003 DB00327 0.762 0.003 DBMET02686 0.762 0.003 DBMET02687 0.777 0.003 DBMET02685 0.777 0.003 DBMET02684 0.666 0.004 DBMET02726 0.797 0.003 DBMET02727 0.666 0.004 DBMET02724 0.797 0.003 DBMET02725 | DBMET02725 | |
| 0.536 | 0.002 | 0.729 | Opioid kappa receptor agonist | 0.696 0.001 DB00956 0.647 0.001 DBMET00420 0.729 0.001 DB00327 0.602 0.001 DBMET02686 0.602 0.001 DBMET02687 0.661 0.001 DBMET02685 0.661 0.001 DBMET02684 0.453 0.002 DBMET02726 0.471 0.002 DBMET02727 0.453 0.002 DBMET02724 0.471 0.002 DBMET02725 | DB00327 | |
| 0.516 | 0.025 | 0.74 | 5 Hydroxytryptamine release stimulant | 0.704 0.007 DB00956 0.531 0.023 DBMET00420 0.704 0.007 DB00327 0.731 0.005 DBMET02686 0.731 0.005 DBMET02687 0.736 0.005 DBMET02685 0.736 0.005 DBMET02684 0.671 0.009 DBMET02726 0.74 0.005 DBMET02727 0.671 0.009 DBMET02724 0.74 0.005 DBMET02725 | DBMET02725 | |
| 0.44 | 0.002 | 0.565 | Toll-Like receptor 4 antagonist | 0.551 0.001 DB00956 0.548 0.001 DBMET00420 0.565 0.001 DB00327 0.414 0.002 DBMET02686 0.414 0.002 DBMET02687 0.442 0.002 DBMET02685 0.442 0.002 DBMET02684 0.379 0.003 DBMET02726 0.403 0.003 DBMET02727 0.379 0.003 DBMET02724 0.403 0.003 DBMET02725 | DB00327 | |
| 0.425 | 0.005 | 0.764 | Sigma receptor antagonist | 0.742 0.003 DB00956 0.694 0.004 DBMET00420 0.764 0.003 DB00327 0.556 0.004 DBMET02686 0.556 0.004 DBMET02687 0.645 0.004 DBMET02685 0.645 0.004 DBMET02684 0.139 0.012 DBMET02726 0.164 0.01 DBMET02727 0.139 0.012 DBMET02724 0.164 0.01 DBMET02725 | DB00327 | |
| 0.432 | 0.057 | 0.789 | Transcription factor NF kappa B inhibitor | 0.534 0.039 DB00956 0.497 0.045 DBMET00420 0.582 0.033 DB00327 0.521 0.041 DBMET02686 0.521 0.041 DBMET02687 0.519 0.041 DBMET02685 0.519 0.041 DBMET02684 0.789 0.014 DBMET02726 0.733 0.017 DBMET02727 0.789 0.014 DBMET02724 0.733 0.017 DBMET02725 | DBMET02724 | |
| 0.358 | 0.02 | 0.419 | P-glycoprotein inhibitor | 0.419 0.014 DB00956 0.327 0.024 DBMET00420 0.336 0.023 DB00327 0.349 0.021 DBMET02686 0.349 0.021 DBMET02687 0.283 0.032 DBMET02685 0.283 0.032 DBMET02684 0.231 0.048 DBMET02726 0.246 0.043 DBMET02727 0.231 0.048 DBMET02724 0.246 0.043 DBMET02725 | DB00956 | |
| 0.335 | 0.08 | 0.466 | Vasodilator, peripheral | 0.397 0.056 DB00956 0.219 0.155 DBMET00420 0.318 0.088 DB00327 0.466 0.036 DBMET02686 0.466 0.036 DBMET02687 0.362 0.069 DBMET02685 0.362 0.069 DBMET02684 0.292 0.101 DBMET02726 0.353 0.072 DBMET02727 0.292 0.101 DBMET02724 0.353 0.072 DBMET02725 | DBMET02687 | |
| 0.266 | 0.012 | 0.62 | Toll-Like receptor antagonist | 0.617 0.003 DB00956 0.564 0.003 DBMET00420 0.62 0.003 DB00327 0.41 0.004 DBMET02686 0.41 0.004 DBMET02687 0.431 0.004 DBMET02685 0.431 0.004 DBMET02684 0.156 0.052 DBMET02726 0.226 0.022 DBMET02727 0.156 0.052 DBMET02724 0.226 0.022 DBMET02725 | DB00327 | |
| 0.298 | 0.046 | 0.395 | 5 Hydroxytryptamine uptake stimulant | 0.366 0.021 DB00956 0.395 0.015 DBMET00420 0.336 0.03 DB00327 0.352 0.025 DBMET02686 0.352 0.025 DBMET02687 0.322 0.035 DBMET02685 0.322 0.035 DBMET02684 | DBMET00420 | |
| 0.263 | 0.026 | 0.426 | Cholinergic | 0.415 0.009 DB00956 0.426 0.009 DBMET00420 0.338 0.014 DB00327 0.309 0.018 DBMET02686 0.309 0.018 DBMET02687 0.277 0.022 DBMET02685 0.277 0.022 DBMET02684 0.127 0.099 DBMET02726 0.127 0.099 DBMET02724 | DBMET00420 | |
| 0.247 | 0.022 | 0.4 | Cholinergic antagonist | 0.334 0.012 DB00956 0.256 0.02 DBMET00420 0.385 0.008 DB00327 0.333 0.012 DBMET02686 0.333 0.012 DBMET02687 0.4 0.008 DBMET02685 0.4 0.008 DBMET02684 0.111 0.082 DBMET02727 0.111 0.082 DBMET02725 | DBMET02684 | |
| 0.24 | 0.022 | 0.39 | Acetylcholine antagonist | 0.324 0.012 DB00956 0.252 0.02 DBMET00420 0.375 0.009 DB00327 0.322 0.012 DBMET02686 0.322 0.012 DBMET02687 0.39 0.008 DBMET02685 0.39 0.008 DBMET02684 | DBMET02684 | |
| 0.237 | 0.029 | 0.482 | Acetylcholine M1 receptor antagonist | 0.369 0.007 DB00956 0.273 0.02 DBMET00420 0.482 0.004 DB00327 0.366 0.007 DBMET02686 0.366 0.007 DBMET02687 0.478 0.004 DBMET02685 0.478 0.004 DBMET02684 0.163 0.063 DBMET02726 0.175 0.055 DBMET02727 0.163 0.063 DBMET02724 0.175 0.055 DBMET02725 | DB00327 | |
| 0.255 | 0.05 | 0.47 | Nitric oxide antagonist | 0.318 0.037 DB00956 0.289 0.043 DBMET00420 0.33 0.035 DB00327 0.338 0.034 DBMET02686 0.338 0.034 DBMET02687 0.343 0.033 DBMET02685 0.343 0.033 DBMET02684 0.47 0.018 DBMET02726 0.42 0.023 DBMET02727 0.47 0.018 DBMET02724 0.42 0.023 DBMET02725 | DBMET02724 | |
| 0.27 | 0.066 | 0.334 | Tumour necrosis factor alpha release inhibitor | 0.206 0.104 DB00956 0.281 0.061 DBMET02686 0.281 0.061 DBMET02687 0.334 0.042 DBMET02726 0.296 0.055 DBMET02727 0.334 0.042 DBMET02724 0.296 0.055 DBMET02725 | DBMET02724 | |
| 0.223 | 0.027 | 0.322 | Acetylcholinesterase inhibitor | 0.322 0.011 DB00956 0.265 0.018 DBMET00420 0.263 0.018 DB00327 0.237 0.023 DBMET02686 0.237 0.023 DBMET02687 0.201 0.033 DBMET02685 0.201 0.033 DBMET02684 | DB00956 | |
| 0.204 | 0.017 | 0.338 | Cyclooxygenase 3 inhibitor | 0.193 0.021 DB00956 0.227 0.012 DBMET00420 0.17 0.033 DB00327 0.175 0.03 DBMET02686 0.175 0.03 DBMET02687 0.148 0.049 DBMET02685 0.148 0.049 DBMET02684 0.338 0.005 DBMET02726 0.26 0.008 DBMET02727 0.338 0.005 DBMET02724 0.26 0.008 DBMET02725 | DBMET02724 | |
| 0.186 | 0.011 | 0.262 | Dopamine agonist | 0.222 0.008 DB00956 0.198 0.01 DBMET00420 0.262 0.006 DB00327 0.202 0.01 DBMET02686 0.202 0.01 DBMET02687 0.251 0.007 DBMET02685 0.251 0.007 DBMET02684 0.099 0.028 DBMET02726 0.106 0.025 DBMET02727 0.099 0.028 DBMET02724 0.106 0.025 DBMET02725 | DB00327 | |
| 0.184 | 0.012 | 0.252 | Prolactin inhibitor | 0.179 0.013 DB00956 0.156 0.02 DBMET00420 0.233 0.005 DB00327 0.212 0.007 DBMET02686 0.212 0.007 DBMET02687 0.252 0.004 DBMET02685 0.252 0.004 DBMET02684 | DBMET02684 | |
| 0.181 | 0.021 | 0.591 | Alpha 2 adrenoreceptor antagonist | 0.427 0.005 DB00956 0.408 0.005 DBMET00420 0.341 0.006 DB00327 0.591 0.004 DBMET02686 0.591 0.004 DBMET02687 0.561 0.004 DBMET02685 0.561 0.004 DBMET02684 0.098 0.049 DBMET02727 0.098 0.049 DBMET02725 | DBMET02687 | |
| 0.171 | 0.016 | 0.235 | Acetylcholine nicotinic antagonist | 0.227 0.01 DB00956 0.192 0.013 DBMET00420 0.199 0.013 DB00327 0.22 0.011 DBMET02686 0.22 0.011 DBMET02687 0.235 0.01 DBMET02685 0.235 0.01 DBMET02684 | DBMET02684 | |
| 0.179 | 0.026 | 0.531 | Expectorant | 0.133 0.043 DB00956 0.114 0.055 DBMET00420 0.116 0.053 DB00327 0.277 0.01 DBMET02686 0.277 0.01 DBMET02687 0.212 0.018 DBMET02685 0.212 0.018 DBMET02684 0.519 0.003 DBMET02726 0.531 0.003 DBMET02727 0.519 0.003 DBMET02724 0.531 0.003 DBMET02725 | DBMET02725 | |
| 0.201 | 0.048 | 0.619 | Antipruritic | 0.528 0.004 DB00956 0.504 0.004 DBMET00420 0.602 0.004 DB00327 0.543 0.004 DBMET02686 0.543 0.004 DBMET02687 0.619 0.004 DBMET02685 0.619 0.004 DBMET02684 0.329 0.01 DBMET02726 0.331 0.01 DBMET02727 0.329 0.01 DBMET02724 0.331 0.01 DBMET02725 | DBMET02684 | |
| 0.211 | 0.059 | 0.448 | Hepatoprotectant | 0.209 0.06 DB00956 0.181 0.079 DBMET00420 0.211 0.059 DB00327 0.304 0.028 DBMET02686 0.304 0.028 DBMET02687 0.302 0.029 DBMET02685 0.302 0.029 DBMET02684 0.448 0.01 DBMET02726 0.409 0.012 DBMET02727 0.448 0.01 DBMET02724 0.409 0.012 DBMET02725 | DBMET02724 | |
| 0.244 | 0.117 | 0.333 | Caspase 3 stimulant | 0.249 0.113 DB00956 0.196 0.175 DBMET00420 0.233 0.128 DB00327 0.295 0.081 DBMET02686 0.295 0.081 DBMET02687 0.266 0.099 DBMET02685 0.266 0.099 DBMET02684 0.247 0.115 DBMET02726 0.333 0.065 DBMET02727 0.247 0.115 DBMET02724 0.333 0.065 DBMET02725 | DBMET02725 | |
| 0.261 | 0.134 | 0.286 | Calcium channel activator | 0.238 0.162 DB00956 0.262 0.133 DBMET00420 0.286 0.106 DBMET02686 0.286 0.106 DBMET02687 0.241 0.158 DBMET02685 0.241 0.158 DBMET02684 | DBMET02687 | |
| 0.151 | 0.032 | 0.197 | Nav1.1 sodium channel blocker | 0.167 0.027 DB00956 0.179 0.024 DB00327 0.18 0.023 DBMET02686 0.18 0.023 DBMET02687 0.197 0.019 DBMET02685 0.197 0.019 DBMET02684 | DBMET02684 | |
| 0.114 | 0.004 | 0.136 | Prolactin release inhibitor | 0.131 0.003 DB00956 0.1 0.004 DBMET00420 0.134 0.003 DB00327 0.129 0.003 DBMET02686 0.129 0.003 DBMET02687 0.136 0.003 DBMET02685 0.136 0.003 DBMET02684 0.103 0.004 DBMET02726 0.103 0.004 DBMET02727 0.103 0.004 DBMET02724 0.103 0.004 DBMET02725 | DBMET02684 | |
| 0.138 | 0.029 | 0.251 | Breast cancer-resistant protein inhibitor | 0.231 0.011 DB00956 0.251 0.009 DBMET00420 0.18 0.016 DB00327 0.184 0.016 DBMET02686 0.184 0.016 DBMET02687 0.155 0.022 DBMET02685 0.155 0.022 DBMET02684 | DBMET00420 | |
| 0.152 | 0.043 | 0.265 | Acetylcholine muscarinic antagonist | 0.209 0.022 DB00956 0.136 0.053 DBMET00420 0.256 0.014 DB00327 0.217 0.02 DBMET02686 0.217 0.02 DBMET02687 0.265 0.012 DBMET02685 0.265 0.012 DBMET02684 | DBMET02684 | |
| 0.134 | 0.026 | 0.552 | Alpha 2a adrenoreceptor antagonist | 0.351 0.005 DB00956 0.343 0.005 DBMET00420 0.379 0.005 DB00327 0.486 0.004 DBMET02686 0.486 0.004 DBMET02687 0.552 0.004 DBMET02685 0.552 0.004 DBMET02684 0.091 0.041 DBMET02727 0.091 0.041 DBMET02725 | DBMET02684 | |
| 0.127 | 0.019 | 0.144 | Alpha 2d adrenoreceptor antagonist | 0.144 0.011 DB00956 0.143 0.011 DBMET00420 0.136 0.014 DB00327 0.14 0.012 DBMET02686 0.14 0.012 DBMET02687 0.138 0.013 DBMET02685 0.138 0.013 DBMET02684 0.098 0.053 DBMET02726 0.096 0.055 DBMET02727 0.098 0.053 DBMET02724 0.096 0.055 DBMET02725 | DB00956 | |
| 0.143 | 0.039 | 0.386 | Alpha adrenoreceptor antagonist | 0.349 0.012 DB00956 0.283 0.017 DBMET00420 0.171 0.032 DB00327 0.386 0.01 DBMET02686 0.386 0.01 DBMET02687 0.245 0.021 DBMET02685 0.245 0.021 DBMET02684 | DBMET02687 | |
| 0.284 | 0.184 | 0.511 | Apoptosis agonist | 0.384 0.122 DBMET02686 0.384 0.122 DBMET02687 0.361 0.133 DBMET02685 0.361 0.133 DBMET02684 0.511 0.071 DBMET02726 0.479 0.081 DBMET02727 0.511 0.071 DBMET02724 0.479 0.081 DBMET02725 | DBMET02724 | |
| 0.113 | 0.015 | 0.113 | Dopamine uptake inhibitor | 0.068 0.031 DB00956 0.051 0.048 DB00327 0.093 0.02 DBMET02686 0.093 0.02 DBMET02687 0.078 0.026 DBMET02685 0.078 0.026 DBMET02684 | ||
| 0.11 | 0.02 | 0.166 | Neuronal nicotinic receptor antagonist | 0.166 0.011 DB00956 0.143 0.013 DBMET00420 0.142 0.013 DB00327 0.144 0.013 DBMET02686 0.144 0.013 DBMET02687 0.157 0.012 DBMET02685 0.157 0.012 DBMET02684 | DB00956 | |
| 0.154 | 0.065 | 0.276 | Protein kinase stimulant | 0.138 0.077 DB00956 0.132 0.082 DBMET00420 0.162 0.06 DB00327 0.177 0.052 DBMET02686 0.177 0.052 DBMET02687 0.176 0.052 DBMET02685 0.176 0.052 DBMET02684 0.276 0.02 DBMET02726 0.269 0.022 DBMET02727 0.276 0.02 DBMET02724 0.269 0.022 DBMET02725 | DBMET02724 | |
| 0.099 | 0.011 | 0.238 | Dopamine D2 agonist | 0.186 0.005 DB00956 0.064 0.019 DBMET00420 0.238 0.005 DB00327 0.164 0.006 DBMET02686 0.164 0.006 DBMET02687 0.219 0.005 DBMET02685 0.219 0.005 DBMET02684 0.13 0.008 DBMET02726 0.128 0.008 DBMET02727 0.13 0.008 DBMET02724 0.128 0.008 DBMET02725 | DB00327 | |
| 0.129 | 0.043 | 0.213 | Alpha 2c adrenoreceptor antagonist | 0.203 0.017 DB00956 0.159 0.029 DBMET00420 0.129 0.044 DB00327 0.213 0.015 DBMET02686 0.213 0.015 DBMET02687 0.155 0.03 DBMET02685 0.155 0.03 DBMET02684 | DBMET02687 | |
| 0.114 | 0.037 | 0.16 | Acetylcholine M3 receptor agonist | 0.15 0.02 DB00956 0.149 0.02 DBMET00420 0.141 0.024 DB00327 0.157 0.016 DBMET02686 0.157 0.016 DBMET02687 0.16 0.015 DBMET02685 0.16 0.015 DBMET02684 0.088 0.053 DBMET02726 0.084 0.057 DBMET02727 0.088 0.053 DBMET02724 0.084 0.057 DBMET02725 | DBMET02684 | |
| 0.233 | 0.169 | 0.468 | Histamine release inhibitor | 0.302 0.122 DBMET02686 0.302 0.122 DBMET02687 0.268 0.143 DBMET02685 0.268 0.143 DBMET02684 0.468 0.042 DBMET02726 0.46 0.045 DBMET02727 0.468 0.042 DBMET02724 0.46 0.045 DBMET02725 | DBMET02724 | |
| 0.13 | 0.072 | 0.155 | Nav1.2 sodium channel blocker | 0.135 0.068 DB00956 0.105 0.104 DB00327 0.155 0.054 DBMET02686 0.155 0.054 DBMET02687 0.138 0.065 DBMET02685 0.138 0.065 DBMET02684 | DBMET02687 | |
| 0.071 | 0.02 | 0.071 | Dopamine transporter inhibitor | 0.051 0.032 DB00956 0.043 0.04 DB00327 0.057 0.027 DBMET02686 0.057 0.027 DBMET02687 0.055 0.028 DBMET02685 0.055 0.028 DBMET02684 | ||
| 0.062 | 0.018 | 0.134 | Dopamine D5 antagonist | 0.097 0.009 DB00956 0.067 0.016 DBMET00420 0.134 0.007 DB00327 0.086 0.011 DBMET02686 0.086 0.011 DBMET02687 0.12 0.008 DBMET02685 0.12 0.008 DBMET02684 | DB00327 | |
| 0.108 | 0.065 | 0.129 | Electron transport complex I inhibitor | 0.129 0.036 DB00956 0.119 0.049 DBMET00420 0.116 0.053 DB00327 0.12 0.047 DBMET02686 0.12 0.047 DBMET02687 0.107 0.068 DBMET02685 0.107 0.068 DBMET02684 | DB00956 | |
| 0.094 | 0.052 | 0.187 | Antineoplastic alkaloid | 0.164 0.024 DB00956 0.132 0.033 DBMET00420 0.183 0.019 DB00327 0.183 0.018 DBMET02686 0.183 0.018 DBMET02687 0.187 0.017 DBMET02685 0.187 0.017 DBMET02684 0.086 0.058 DBMET02726 0.088 0.056 DBMET02727 0.086 0.058 DBMET02724 0.088 0.056 DBMET02725 | DBMET02684 | |
| 0.17 | 0.132 | 0.343 | Vasodilator | 0.167 0.134 DB00956 0.167 0.135 DBMET00420 0.16 0.143 DB00327 0.277 0.057 DBMET02686 0.277 0.057 DBMET02687 0.264 0.062 DBMET02685 0.264 0.062 DBMET02684 0.343 0.035 DBMET02726 0.302 0.047 DBMET02727 0.343 0.035 DBMET02724 0.302 0.047 DBMET02725 | DBMET02724 | |
| 0.038 | 0.006 | 0.065 | Dopamine D1 agonist | 0.038 0.006 DB00956 0.065 0.004 DBMET00420 0.055 0.004 DB00327 0.037 0.006 DBMET02686 0.037 0.006 DBMET02687 0.053 0.004 DBMET02685 0.053 0.004 DBMET02684 0.046 0.005 DBMET02726 0.047 0.005 DBMET02727 0.046 0.005 DBMET02724 0.047 0.005 DBMET02725 | DBMET00420 | |
| 0.106 | 0.077 | 0.106 | Anesthetic local | |||
| 0.045 | 0.018 | 0.098 | Nicotinic receptor beta4 subunit antagonist | 0.061 0.012 DB00956 0.098 0.006 DBMET00420 0.064 0.011 DB00327 0.057 0.013 DBMET02686 0.057 0.013 DBMET02687 0.063 0.011 DBMET02685 0.063 0.011 DBMET02684 | DBMET00420 | |
| 0.044 | 0.018 | 0.115 | Nociceptin (N/OFQ) receptor antagonist | 0.075 0.008 DB00956 0.053 0.013 DBMET00420 0.112 0.005 DB00327 0.068 0.009 DBMET02686 0.068 0.009 DBMET02687 0.115 0.005 DBMET02685 0.115 0.005 DBMET02684 | DBMET02684 | |
| 0.085 | 0.06 | 0.09 | Calcium antagonist | 0.09 0.056 DB00956 | DB00956 | |
| 0.056 | 0.034 | 0.08 | Nicotinic receptor alpha7 subunit antagonist | 0.08 0.017 DB00956 0.076 0.019 DBMET00420 0.064 0.025 DB00327 0.063 0.026 DBMET02686 0.063 0.026 DBMET02687 0.065 0.024 DBMET02685 0.065 0.024 DBMET02684 | DB00956 | |
| 0.167 | 0.145 | 0.631 | Antioxidant | 0.179 0.133 DBMET00420 0.23 0.095 DB00327 0.331 0.052 DBMET02686 0.331 0.052 DBMET02687 0.382 0.038 DBMET02685 0.382 0.038 DBMET02684 0.631 0.009 DBMET02726 0.516 0.018 DBMET02727 0.631 0.009 DBMET02724 0.516 0.018 DBMET02725 | DBMET02724 | |
| 0.071 | 0.056 | 0.071 | Acetylcholine M4 receptor antagonist | |||
| 0.06 | 0.045 | 0.064 | Adrenaline uptake inhibitor | 0.06 0.044 DB00956 0.064 0.04 DBMET02686 0.064 0.04 DBMET02687 0.059 0.046 DBMET02685 0.059 0.046 DBMET02684 | DBMET02687 | |
| 0.021 | 0.006 | 0.083 | NMDA receptor phencyclidine site antagonist | 0.065 0.003 DB00956 0.083 0.002 DBMET00420 0.072 0.003 DB00327 0.06 0.003 DBMET02686 0.06 0.003 DBMET02687 0.071 0.003 DBMET02685 0.071 0.003 DBMET02684 | DBMET00420 | |
| 0.082 | 0.069 | 0.197 | Antiadrenergic | 0.156 0.034 DB00956 0.156 0.034 DBMET00420 0.106 0.052 DB00327 0.197 0.025 DBMET02686 0.197 0.025 DBMET02687 0.161 0.033 DBMET02685 0.161 0.033 DBMET02684 | DBMET02687 | |
| 0.048 | 0.037 | 0.111 | Nicotinic receptor alpha4 subunit antagonist | 0.055 0.026 DB00956 0.111 0.007 DBMET00420 0.056 0.025 DB00327 0.05 0.032 DBMET02686 0.05 0.032 DBMET02687 0.056 0.025 DBMET02685 0.056 0.025 DBMET02684 | DBMET00420 | |
| 0.076 | 0.072 | 0.162 | Adrenaline antagonist | 0.148 0.035 DB00956 0.148 0.035 DBMET00420 0.098 0.055 DB00327 0.162 0.031 DBMET02686 0.162 0.031 DBMET02687 0.122 0.043 DBMET02685 0.122 0.043 DBMET02684 | DBMET02687 | |
| 0.04 | 0.036 | 0.044 | Nicotinic receptor alpha3 subunit antagonist | 0.044 0.03 DB00956 0.043 0.031 DB00327 0.042 0.032 DBMET02685 0.042 0.032 DBMET02684 | DB00956 | |
| 0.093 | 0.093 | 0.162 | DNA polymerase I inhibitor | 0.139 0.056 DBMET02686 0.139 0.056 DBMET02687 0.157 0.046 DBMET02685 0.157 0.046 DBMET02684 0.162 0.043 DBMET02726 0.105 0.081 DBMET02727 0.162 0.043 DBMET02724 0.105 0.081 DBMET02725 | DBMET02724 | |
| 0.045 | 0.052 | 0.069 | Acetylcholine M2 receptor agonist | 0.064 0.025 DB00956 0.056 0.034 DBMET00420 0.06 0.029 DB00327 0.068 0.021 DBMET02686 0.068 0.021 DBMET02687 0.069 0.02 DBMET02685 0.069 0.02 DBMET02684 | DBMET02684 | |
| 0.158 | 0.165 | 0.609 | Hypoglycemic | 0.189 0.123 DB00327 0.258 0.072 DBMET02686 0.258 0.072 DBMET02687 0.302 0.052 DBMET02685 0.302 0.052 DBMET02684 0.609 0.008 DBMET02726 0.528 0.013 DBMET02727 0.609 0.008 DBMET02724 0.528 0.013 DBMET02725 | DBMET02724 | |
| 0.13 | 0.14 | 0.239 | Lipocortins synthesis antagonist | 0.219 0.045 DB00956 0.208 0.052 DBMET00420 0.239 0.037 DB00327 0.211 0.05 DBMET02686 0.211 0.05 DBMET02687 0.217 0.047 DBMET02685 0.217 0.047 DBMET02684 0.171 0.079 DBMET02726 0.166 0.085 DBMET02727 0.171 0.079 DBMET02724 0.166 0.085 DBMET02725 | DB00327 | |
| 0.252 | 0.264 | 0.741 | Antiinflammatory | 0.323 0.194 DB00956 0.298 0.218 DBMET00420 0.366 0.161 DB00327 0.459 0.106 DBMET02686 0.459 0.106 DBMET02687 0.476 0.098 DBMET02685 0.476 0.098 DBMET02684 0.741 0.024 DBMET02726 0.663 0.038 DBMET02727 0.741 0.024 DBMET02724 0.663 0.038 DBMET02725 | DBMET02724 | |
| 0.013 | 0.026 | 0.036 | Nociceptin (N/OFQ) receptor agonist | 0.021 0.015 DB00956 0.024 0.013 DBMET00420 0.035 0.009 DB00327 0.02 0.015 DBMET02686 0.02 0.015 DBMET02687 0.036 0.008 DBMET02685 0.036 0.008 DBMET02684 | DBMET02684 | |
| 0.142 | 0.156 | 0.552 | Free radical scavenger | 0.194 0.103 DB00327 0.264 0.063 DBMET02686 0.264 0.063 DBMET02687 0.336 0.042 DBMET02685 0.336 0.042 DBMET02684 0.552 0.012 DBMET02726 0.434 0.024 DBMET02727 0.552 0.012 DBMET02724 0.434 0.024 DBMET02725 | DBMET02724 | |
| 0.05 | 0.068 | 0.159 | Alpha 1a adrenoreceptor antagonist | 0.159 0.022 DB00956 0.096 0.038 DBMET00420 0.116 0.03 DBMET02686 0.116 0.03 DBMET02687 | DB00956 | |
| 0.089 | 0.113 | 0.098 | Microtubule formation inhibitor | 0.098 0.095 DBMET02686 0.098 0.095 DBMET02687 0.098 0.095 DBMET02727 0.098 0.095 DBMET02725 | DBMET02725 | |
| 0.04 | 0.068 | 0.067 | Glucose-6-phosphate translocase inhibitor | 0.067 0.018 DBMET02726 0.064 0.02 DBMET02727 0.067 0.018 DBMET02724 0.064 0.02 DBMET02725 | DBMET02724 | |
| 0.049 | 0.08 | 0.168 | Alpha 1 adrenoreceptor antagonist | 0.168 0.026 DB00956 0.092 0.047 DBMET00420 0.12 0.037 DBMET02686 0.12 0.037 DBMET02687 | DB00956 | |
| 0.174 | 0.207 | 0.252 | Vasodilator, coronary | 0.252 0.133 DBMET02726 0.24 0.144 DBMET02727 0.252 0.133 DBMET02724 0.24 0.144 DBMET02725 | DBMET02724 | |
| 0.075 | 0.112 | 0.12 | Estrogen receptor beta antagonist | 0.1 0.065 DB00956 0.096 0.072 DBMET00420 0.12 0.032 DB00327 0.102 0.061 DBMET02686 0.102 0.061 DBMET02687 0.111 0.045 DBMET02685 0.111 0.045 DBMET02684 | DB00327 | |
| 0.044 | 0.081 | 0.168 | Dopamine D1 antagonist | 0.088 0.029 DB00956 0.168 0.013 DB00327 0.089 0.029 DBMET02686 0.089 0.029 DBMET02687 0.138 0.017 DBMET02685 0.138 0.017 DBMET02684 | DB00327 | |
| 0.162 | 0.201 | 0.353 | Hypoxia-inducible factor 1 alpha inhibitor | 0.225 0.123 DB00956 0.25 0.1 DB00327 0.311 0.06 DBMET02686 0.311 0.06 DBMET02687 0.306 0.063 DBMET02685 0.306 0.063 DBMET02684 0.269 0.084 DBMET02726 0.353 0.044 DBMET02727 0.269 0.084 DBMET02724 0.353 0.044 DBMET02725 | DBMET02725 | |
| 0.024 | 0.068 | 0.049 | Estrogen agonist | 0.049 0.036 DB00327 0.049 0.036 DBMET02685 0.049 0.036 DBMET02684 0.047 0.037 DBMET02727 0.047 0.037 DBMET02725 | DBMET02684 | |
| 0.087 | 0.133 | 0.129 | Estrogen antagonist | 0.107 0.081 DB00956 0.108 0.079 DBMET00420 0.129 0.04 DB00327 0.115 0.065 DBMET02686 0.115 0.065 DBMET02687 0.124 0.049 DBMET02685 0.124 0.049 DBMET02684 | DB00327 | |
| 0.058 | 0.104 | 0.086 | Orexin receptor 1 antagonist | 0.086 0.027 DB00956 0.077 0.039 DBMET02686 0.077 0.039 DBMET02687 | DB00956 | |
| 0.03 | 0.077 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET02726 0.041 0.04 DBMET02724 | DBMET02724 | |
| 0.009 | 0.059 | 0.045 | Estrogen receptor beta agonist | 0.045 0.02 DB00327 0.029 0.024 DBMET02685 0.029 0.024 DBMET02684 | DB00327 | |
| 0.027 | 0.079 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.029 DBMET00420 0.036 0.031 DB00327 0.035 0.034 DBMET02685 0.035 0.034 DBMET02684 | DB00327 | |
| 0.01 | 0.065 | 0.028 | RNA-directed RNA polymerase stimulant | 0.026 0.024 DB00327 0.027 0.023 DBMET02686 0.027 0.023 DBMET02687 0.028 0.022 DBMET02685 0.028 0.022 DBMET02684 | DBMET02684 | |
| 0.172 | 0.228 | 0.517 | Immunosuppressant | 0.306 0.111 DB00956 0.362 0.08 DBMET00420 0.357 0.083 DB00327 0.423 0.055 DBMET02686 0.423 0.055 DBMET02687 0.452 0.046 DBMET02685 0.452 0.046 DBMET02684 0.517 0.029 DBMET02726 0.506 0.031 DBMET02727 0.517 0.029 DBMET02724 0.506 0.031 DBMET02725 | DBMET02724 | |
| 0.039 | 0.095 | 0.175 | Dopamine antagonist | 0.175 0.022 DB00956 0.096 0.04 DBMET00420 0.128 0.03 DB00327 0.108 0.035 DBMET02686 0.108 0.035 DBMET02687 0.093 0.041 DBMET02685 0.093 0.041 DBMET02684 | DB00956 | |
| 0.101 | 0.159 | 0.425 | NOS3 expression enhancer | 0.13 0.097 DB00956 0.167 0.058 DB00327 0.141 0.082 DBMET02686 0.141 0.082 DBMET02687 0.168 0.057 DBMET02685 0.168 0.057 DBMET02684 0.425 0.007 DBMET02726 0.263 0.024 DBMET02727 0.425 0.007 DBMET02724 0.263 0.024 DBMET02725 | DBMET02724 | |
| 0.023 | 0.083 | 0.032 | Tubulin agonist | 0.032 0.031 DBMET02686 0.032 0.031 DBMET02687 0.032 0.03 DBMET02685 0.032 0.03 DBMET02684 | DBMET02684 | |
| 0.11 | 0.173 | 0.254 | Interleukin 6 antagonist | 0.159 0.077 DB00956 0.174 0.06 DB00327 0.196 0.043 DBMET02686 0.196 0.043 DBMET02687 0.204 0.038 DBMET02685 0.204 0.038 DBMET02684 0.236 0.026 DBMET02726 0.254 0.022 DBMET02727 0.236 0.026 DBMET02724 0.254 0.022 DBMET02725 | DBMET02725 | |
| 0.119 | 0.192 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.138 0.081 DB00327 0.133 0.105 DBMET02686 0.133 0.105 DBMET02687 0.142 0.065 DBMET02685 0.142 0.065 DBMET02684 0.131 0.115 DBMET02726 0.139 0.076 DBMET02727 0.131 0.115 DBMET02724 0.139 0.076 DBMET02725 | DBMET02684 | |
| 0.035 | 0.11 | 0.189 | Antineoplastic antibiotic | 0.086 0.053 DBMET02686 0.086 0.053 DBMET02687 0.093 0.049 DBMET02685 0.093 0.049 DBMET02684 0.189 0.023 DBMET02726 0.174 0.026 DBMET02727 0.189 0.023 DBMET02724 0.174 0.026 DBMET02725 | DBMET02724 | |
| 0.102 | 0.18 | 0.176 | Melanin inhibitor | 0.129 0.116 DBMET00420 0.133 0.108 DB00327 0.133 0.108 DBMET02685 0.133 0.108 DBMET02684 0.155 0.075 DBMET02726 0.176 0.055 DBMET02727 0.155 0.075 DBMET02724 0.176 0.055 DBMET02725 | DBMET02725 | |
| 0.048 | 0.133 | 0.124 | Glycine receptor agonist | 0.069 0.057 DB00327 0.112 0.015 DBMET02686 0.112 0.015 DBMET02687 0.124 0.011 DBMET02685 0.124 0.011 DBMET02684 0.09 0.028 DBMET02726 0.115 0.014 DBMET02727 0.09 0.028 DBMET02724 0.115 0.014 DBMET02725 | DBMET02684 | |
| 0.018 | 0.107 | 0.044 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.044 0.036 DBMET02685 0.044 0.036 DBMET02684 | DBMET02684 | |
| 0.073 | 0.168 | 0.25 | Lipid peroxidase inhibitor | 0.121 0.092 DB00327 0.126 0.088 DBMET02686 0.126 0.088 DBMET02687 0.178 0.051 DBMET02685 0.178 0.051 DBMET02684 0.25 0.027 DBMET02726 0.224 0.033 DBMET02727 0.25 0.027 DBMET02724 0.224 0.033 DBMET02725 | DBMET02724 | |
| 0.022 | 0.12 | 0.105 | Dopamine D2 antagonist | 0.105 0.031 DB00956 0.055 0.053 DBMET00420 0.071 0.043 DB00327 0.104 0.031 DBMET02686 0.104 0.031 DBMET02687 0.086 0.037 DBMET02685 0.086 0.037 DBMET02684 | DB00956 | |
| 0.058 | 0.158 | 0.154 | Alpha 2b adrenoreceptor antagonist | 0.154 0.037 DB00956 0.134 0.048 DBMET00420 0.096 0.079 DB00327 0.154 0.037 DBMET02686 0.154 0.037 DBMET02687 0.118 0.06 DBMET02685 0.118 0.06 DBMET02684 | DBMET02687 | |
| 0.039 | 0.146 | 0.073 | Orexin receptor antagonist | 0.073 0.035 DB00956 0.063 0.051 DBMET02686 0.063 0.051 DBMET02687 | DB00956 | |
| 0.041 | 0.149 | 0.064 | Lipocortins synthesis agonist | 0.054 0.052 DB00956 0.054 0.051 DBMET00420 0.058 0.04 DB00327 0.056 0.044 DBMET02686 0.056 0.044 DBMET02687 0.058 0.041 DBMET02685 0.058 0.041 DBMET02684 0.064 0.029 DBMET02726 0.064 0.028 DBMET02727 0.064 0.029 DBMET02724 0.064 0.028 DBMET02725 | DBMET02725 | |
| 0.054 | 0.172 | 0.125 | 5 Hydroxytryptamine 2B antagonist | 0.125 0.056 DB00956 | DB00956 | |
| 0.15 | 0.274 | 0.386 | Apoptosis antagonist | 0.254 0.124 DBMET02686 0.254 0.124 DBMET02687 0.275 0.104 DBMET02685 0.275 0.104 DBMET02684 0.386 0.042 DBMET02726 0.368 0.048 DBMET02727 0.386 0.042 DBMET02724 0.368 0.048 DBMET02725 | DBMET02724 | |
| 0.046 | 0.18 | 0.109 | Bronchodilator | 0.109 0.053 DBMET02686 0.109 0.053 DBMET02687 | DBMET02687 | |
| 0.008 | 0.154 | 0.03 | Nicotinic alpha3beta4 receptor agonist | 0.03 0.021 DBMET00420 | DBMET00420 | |
| 0.038 | 0.186 | 0.126 | Glycine receptor antagonist | 0.086 0.047 DBMET02686 0.086 0.047 DBMET02687 0.103 0.03 DBMET02685 0.103 0.03 DBMET02684 0.126 0.015 DBMET02726 0.119 0.019 DBMET02727 0.126 0.015 DBMET02724 0.119 0.019 DBMET02725 | DBMET02724 | |
| 0.049 | 0.198 | 0.09 | Anabolic | 0.09 0.079 DBMET02685 0.09 0.079 DBMET02684 | DBMET02684 | |
| 0.006 | 0.155 | 0.033 | Acetylcholine M4 receptor agonist | 0.033 0.019 DBMET02686 0.033 0.019 DBMET02687 0.03 0.022 DBMET02685 0.03 0.022 DBMET02684 | DBMET02687 | |
| 0.047 | 0.199 | 0.103 | Cystathionine beta-synthase inhibitor | 0.103 0.073 DB00327 | DB00327 | |
| 0.015 | 0.172 | 0.063 | 5 Hydroxytryptamine 1A antagonist | 0.063 0.05 DB00956 | DB00956 | |
| 0.011 | 0.168 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 DB00327 | DB00327 | |
| 0.035 | 0.202 | 0.112 | Acetylcholine agonist | 0.112 0.04 DB00956 0.109 0.041 DBMET00420 0.08 0.066 DB00327 0.104 0.044 DBMET02686 0.104 0.044 DBMET02687 0.104 0.044 DBMET02685 0.104 0.044 DBMET02684 | DB00956 | |
| 0.136 | 0.304 | 0.236 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.163 DB00956 0.2 0.135 DBMET00420 0.236 0.082 DB00327 0.2 0.136 DBMET02685 0.2 0.136 DBMET02684 | DB00327 | |
| 0.013 | 0.183 | 0.079 | NMDA 2C receptor antagonist | 0.079 0.026 DB00327 0.064 0.039 DBMET02685 0.064 0.039 DBMET02684 | DB00327 | |
| 0.019 | 0.192 | 0.065 | 5 Hydroxytryptamine 1 antagonist | 0.065 0.058 DB00956 | DB00956 | |
| 0.142 | 0.321 | 0.376 | Interleukin 2 agonist | 0.234 0.137 DB00327 0.212 0.169 DBMET02686 0.212 0.169 DBMET02687 0.243 0.127 DBMET02685 0.243 0.127 DBMET02684 0.376 0.035 DBMET02726 0.376 0.035 DBMET02727 0.376 0.035 DBMET02724 0.376 0.035 DBMET02725 | DBMET02725 | |
| 0.007 | 0.209 | 0.056 | 5 Hydroxytryptamine 2C agonist | 0.056 0.023 DBMET00420 | DBMET00420 | |
| 0.072 | 0.281 | 0.214 | Aldehyde oxidase inhibitor | 0.198 0.105 DB00327 0.208 0.1 DBMET02686 0.208 0.1 DBMET02687 0.214 0.097 DBMET02685 0.214 0.097 DBMET02684 | DBMET02684 | |
| 0.006 | 0.219 | 0.041 | Acetylcholine M1 receptor agonist | 0.037 0.035 DB00956 0.04 0.033 DBMET02686 0.04 0.033 DBMET02687 0.041 0.032 DBMET02685 0.041 0.032 DBMET02684 | DBMET02684 | |
| 0.072 | 0.288 | 0.142 | Growth hormone agonist | 0.126 0.111 DBMET02686 0.126 0.111 DBMET02687 0.142 0.094 DBMET02685 0.142 0.094 DBMET02684 | DBMET02684 | |
| 0.039 | 0.264 | 0.182 | Alkylator | 0.122 0.066 DBMET02726 0.182 0.032 DBMET02727 0.122 0.066 DBMET02724 0.182 0.032 DBMET02725 | DBMET02725 | |
| 0.067 | 0.297 | 0.477 | Immunostimulant | 0.202 0.119 DBMET02686 0.202 0.119 DBMET02687 0.261 0.092 DBMET02685 0.261 0.092 DBMET02684 0.477 0.032 DBMET02726 0.474 0.033 DBMET02727 0.477 0.032 DBMET02724 0.474 0.033 DBMET02725 | DBMET02724 | |
| 0.067 | 0.298 | 0.255 | Platelet adhesion inhibitor | 0.243 0.052 DBMET02726 0.255 0.048 DBMET02727 0.243 0.052 DBMET02724 0.255 0.048 DBMET02725 | DBMET02725 | |
| 0.016 | 0.249 | 0.091 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 DBMET02726 0.091 0.015 DBMET02727 0.08 0.019 DBMET02724 0.091 0.015 DBMET02725 | DBMET02725 | |
| 0.009 | 0.244 | 0.05 | Acetylcholine muscarinic agonist | 0.05 0.043 DB00956 0.05 0.044 DBMET02686 0.05 0.044 DBMET02687 0.049 0.045 DBMET02685 0.049 0.045 DBMET02684 | DBMET02687 | |
| 0.099 | 0.349 | 0.535 | Antithrombotic | 0.482 0.032 DBMET02726 0.535 0.024 DBMET02727 0.482 0.032 DBMET02724 0.535 0.024 DBMET02725 | DBMET02725 | |
| 0.11 | 0.36 | 0.302 | Sodium/bile acid cotransporter inhibitor | 0.2 0.188 DB00956 0.261 0.117 DB00327 0.291 0.088 DBMET02686 0.291 0.088 DBMET02687 0.302 0.077 DBMET02685 0.302 0.077 DBMET02684 0.209 0.176 DBMET02727 0.209 0.176 DBMET02725 | DBMET02684 | |
| 0.009 | 0.26 | 0.052 | Aromatase inhibitor | 0.052 0.047 DBMET00420 | DBMET00420 | |
| 0.079 | 0.34 | 0.168 | Cyclic AMP phosphodiesterase inhibitor | 0.168 0.125 DBMET02726 0.168 0.125 DBMET02724 | DBMET02724 | |
| 0.151 | 0.414 | 0.355 | Caspase 9 stimulant | 0.27 0.229 DB00956 0.258 0.244 DBMET00420 0.343 0.151 DBMET02686 0.343 0.151 DBMET02687 0.302 0.192 DBMET02685 0.302 0.192 DBMET02684 0.285 0.211 DBMET02726 0.355 0.142 DBMET02727 0.285 0.211 DBMET02724 0.355 0.142 DBMET02725 | DBMET02725 | |
| 0.033 | 0.313 | 0.213 | Toll-Like receptor 9 antagonist | 0.174 0.048 DB00956 0.213 0.03 DBMET00420 0.163 0.055 DB00327 | DBMET00420 | |
| 0.008 | 0.297 | 0.047 | Dopamine D5 agonist | 0.047 0.02 DBMET00420 | DBMET00420 | |
| 0.07 | 0.362 | 0.187 | Neurotrophic factor enhancer | 0.161 0.122 DB00956 0.153 0.134 DBMET00420 0.183 0.094 DB00327 0.185 0.092 DBMET02686 0.185 0.092 DBMET02687 0.186 0.091 DBMET02685 0.186 0.091 DBMET02684 0.187 0.09 DBMET02726 0.165 0.117 DBMET02727 0.187 0.09 DBMET02724 0.165 0.117 DBMET02725 | DBMET02724 | |
| 0.086 | 0.379 | 0.32 | Cholesterol antagonist | 0.317 0.081 DBMET02726 0.32 0.079 DBMET02727 0.317 0.081 DBMET02724 0.32 0.079 DBMET02725 | DBMET02725 | |
| 0.026 | 0.348 | 0.125 | Creatine kinase inhibitor | 0.124 0.038 DB00327 0.125 0.037 DBMET02685 0.125 0.037 DBMET02684 | DBMET02684 | |
| 0.025 | 0.35 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.052 DBMET02726 0.086 0.064 DBMET02727 0.092 0.052 DBMET02724 0.086 0.064 DBMET02725 | DBMET02724 | |
| 0.039 | 0.364 | 0.47 | Angiogenesis stimulant | 0.47 0.014 DBMET02726 0.467 0.014 DBMET02727 0.47 0.014 DBMET02724 0.467 0.014 DBMET02725 | DBMET02724 | |
| 0.047 | 0.375 | 0.082 | CC chemokine 5 receptor agonist | 0.082 0.058 DB00327 0.079 0.067 DBMET02685 0.079 0.067 DBMET02684 | DB00327 | |
| 0.04 | 0.371 | 0.097 | Transcription factor NF kappa B stimulant | 0.091 0.049 DBMET02726 0.097 0.041 DBMET02727 0.091 0.049 DBMET02724 0.097 0.041 DBMET02725 | DBMET02725 | |
| 0.005 | 0.342 | 0.063 | NMDA 2 receptor antagonist | 0.063 0.059 DBMET02685 0.063 0.059 DBMET02684 | DBMET02684 | |
| 0.012 | 0.359 | 0.026 | Toll-Like receptor 4 agonist | 0.026 0.02 DBMET02726 0.026 0.019 DBMET02727 0.026 0.02 DBMET02724 0.026 0.019 DBMET02725 | DBMET02725 | |
| 0.018 | 0.364 | 0.08 | Topoisomerase II alpha inhibitor | 0.08 0.053 DBMET02727 0.08 0.053 DBMET02725 | DBMET02725 | |
| 0.002 | 0.355 | 0.045 | Arginase inhibitor | 0.045 0.018 DBMET02726 0.045 0.018 DBMET02724 | DBMET02724 | |
| 0.008 | 0.373 | 0.184 | Cathepsin L2 inhibitor | 0.184 0.005 DBMET02727 0.184 0.005 DBMET02725 | DBMET02725 | |
| 0.025 | 0.397 | 0.167 | AMP-activated protein kinase stimulant | 0.134 0.039 DBMET02726 0.167 0.019 DBMET02727 0.134 0.039 DBMET02724 0.167 0.019 DBMET02725 | DBMET02725 | |
| 0.01 | 0.389 | 0.106 | Na+ K+ transporting ATPase inhibitor | 0.078 0.052 DBMET02685 0.078 0.052 DBMET02684 0.098 0.034 DBMET02726 0.106 0.026 DBMET02727 0.098 0.034 DBMET02724 0.106 0.026 DBMET02725 | DBMET02725 | |
| 0.013 | 0.403 | 0.066 | Antibiotic Aminoglycoside-like | 0.059 0.009 DBMET02726 0.066 0.007 DBMET02727 0.059 0.009 DBMET02724 0.066 0.007 DBMET02725 | DBMET02725 | |
| 0.01 | 0.402 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET02726 0.058 0.029 DBMET02727 0.063 0.023 DBMET02724 0.058 0.029 DBMET02725 | DBMET02724 | |
| 0.038 | 0.443 | 0.172 | Antiamyloidogenic | 0.172 0.121 DBMET02727 0.172 0.121 DBMET02725 | DBMET02725 | |
| 0.031 | 0.437 | 0.14 | Adenylate cyclase inhibitor | 0.094 0.09 DB00327 0.14 0.052 DBMET02685 0.14 0.052 DBMET02684 | DBMET02684 | |
| 0.017 | 0.431 | 0.118 | M18 aspartyl aminopeptidase inhibitor | 0.1 0.092 DBMET02686 0.1 0.092 DBMET02687 0.118 0.072 DBMET02685 0.118 0.072 DBMET02684 | DBMET02684 | |
| 0.016 | 0.447 | 0.114 | Topoisomerase I inhibitor | 0.114 0.06 DBMET02726 0.108 0.064 DBMET02727 0.114 0.06 DBMET02724 0.108 0.064 DBMET02725 | DBMET02724 | |
| 0.048 | 0.484 | 0.161 | Interferon gamma antagonist | 0.161 0.066 DBMET02726 0.16 0.066 DBMET02727 0.161 0.066 DBMET02724 0.16 0.066 DBMET02725 | DBMET02724 | |
| 0.016 | 0.469 | 0.137 | Topoisomerase II inhibitor | 0.129 0.06 DBMET02726 0.137 0.056 DBMET02727 0.129 0.06 DBMET02724 0.137 0.056 DBMET02725 | DBMET02725 | |
| 0.03 | 0.485 | 0.201 | Platelet antagonist | 0.201 0.1 DBMET02726 0.201 0.1 DBMET02724 | DBMET02724 | |
| 0.007 | 0.462 | 0.048 | Mannosidase inhibitor | 0.048 0.027 DBMET02726 0.043 0.035 DBMET02727 0.048 0.027 DBMET02724 0.043 0.035 DBMET02725 | DBMET02724 | |
| 0.027 | 0.487 | 0.115 | Amylase inhibitor | 0.099 0.098 DBMET02726 0.115 0.085 DBMET02727 0.099 0.098 DBMET02724 0.115 0.085 DBMET02725 | DBMET02725 | |
| 0.01 | 0.472 | 0.1 | Androgen antagonist | 0.1 0.047 DBMET02685 0.1 0.047 DBMET02684 | DBMET02684 | |
| 0.026 | 0.491 | 0.126 | Arachidonic acid antagonist | 0.126 0.118 DB00327 | DB00327 | |
| 0.005 | 0.473 | 0.04 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 DBMET02726 0.04 0.01 DBMET02727 0.028 0.014 DBMET02724 0.04 0.01 DBMET02725 | DBMET02725 | |
| 0.006 | 0.509 | 0.231 | Selectin antagonist | 0.231 0.009 DBMET02726 0.231 0.009 DBMET02727 0.231 0.009 DBMET02724 0.231 0.009 DBMET02725 | DBMET02725 | |
| 0.034 | 0.555 | 0.225 | Interleukin agonist | 0.178 0.141 DBMET02726 0.225 0.099 DBMET02727 0.178 0.141 DBMET02724 0.225 0.099 DBMET02725 | DBMET02725 | |
| 0.031 | 0.571 | 0.123 | Adenylate cyclase stimulant | 0.123 0.118 DBMET02685 0.123 0.118 DBMET02684 | DBMET02684 | |
| 0.025 | 0.591 | 0.265 | Insulin secretagoues | 0.265 0.017 DBMET02726 0.15 0.075 DBMET02727 0.265 0.017 DBMET02724 0.15 0.075 DBMET02725 | DBMET02724 | |
| 0.073 | 0.642 | 0.134 | CC chemokine 6 receptor antagonist | 0.128 0.078 DBMET02726 0.134 0.056 DBMET02727 0.128 0.078 DBMET02724 0.134 0.056 DBMET02725 | DBMET02725 | |
| 0.074 | 0.664 | 0.352 | Peptidyltransferase inhibitor | 0.329 0.016 DBMET02726 0.352 0.012 DBMET02727 0.329 0.016 DBMET02724 0.352 0.012 DBMET02725 | DBMET02725 | |
| 0.046 | 0.655 | 0.658 | Cyclophilin D inhibitor | 0.658 0.019 DBMET02726 0.507 0.048 DBMET02727 0.658 0.019 DBMET02724 0.507 0.048 DBMET02725 | DBMET02724 | |
| 0.007 | 0.628 | 0.172 | Diuretic | 0.172 0.059 DBMET02726 0.138 0.087 DBMET02727 0.172 0.059 DBMET02724 0.138 0.087 DBMET02725 | DBMET02724 | |
| 0.029 | 0.651 | 0.342 | Antiobesity | 0.222 0.185 DBMET02685 0.222 0.185 DBMET02684 0.342 0.091 DBMET02726 0.342 0.091 DBMET02724 | DBMET02724 | |
| 0.019 | 0.659 | 0.182 | Hemostatic | 0.154 0.063 DBMET02726 0.182 0.041 DBMET02727 0.154 0.063 DBMET02724 0.182 0.041 DBMET02725 | DBMET02725 | |
| 0.01 | 0.672 | 0.058 | Cathepsin F inhibitor | 0.058 0.006 DBMET02727 0.058 0.006 DBMET02725 | DBMET02725 | |
| 0.016 | 0.683 | 0.269 | DNA synthesis inhibitor | 0.226 0.087 DBMET02726 0.269 0.056 DBMET02727 0.226 0.087 DBMET02724 0.269 0.056 DBMET02725 | DBMET02725 | |
| 0.02 | 0.716 | 0.176 | ATPase inhibitor | 0.176 0.063 DBMET02726 0.138 0.124 DBMET02727 0.176 0.063 DBMET02724 0.138 0.124 DBMET02725 | DBMET02724 | |
| 0.002 | 0.702 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | 0.026 0.019 DBMET02726 0.026 0.019 DBMET02724 | DBMET02724 | |
| 0.013 | 0.726 | 0.116 | Cell adhesion inhibitor | 0.116 0.068 DBMET02726 0.116 0.068 DBMET02724 | DBMET02724 | |
| 0.002 | 0.722 | 0.025 | Sodium/glucose cotransporter inhibitor | 0.025 0.018 DBMET02726 0.025 0.018 DBMET02724 | DBMET02724 | |
| 0.024 | 0.762 | 0.318 | Immunomodulator | 0.318 0.072 DBMET02726 0.24 0.123 DBMET02727 0.318 0.072 DBMET02724 0.24 0.123 DBMET02725 | DBMET02724 | |
| 0.009 | 0.767 | 0.168 | Thrombolytic | 0.161 0.074 DBMET02726 0.168 0.069 DBMET02727 0.161 0.074 DBMET02724 0.168 0.069 DBMET02725 | DBMET02725 | |
| 0.012 | 0.784 | 0.544 | Antibacterial | 0.467 0.051 DBMET02726 0.544 0.03 DBMET02727 0.467 0.051 DBMET02724 0.544 0.03 DBMET02725 | DBMET02725 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |